Pharmaceutical giant Pfizer has achieved a big success. Canada has allowed the company to give the vaccine to children in the age group of 12 to 15. Earlier on Friday, Pfizer and BioNtech requested the EU drug regulators to approve the companies’ corona virus vaccine for children between the ages of 12 and 15 years. The company had said the move could provide access to vaccines to young and low-risk populations in Europe.
Both companies said their application to the European Medicine Agency was based on an advanced study. They conducted the study on more than 2,000 adolescents. They found that vaccine was safe and effective. The companies will monitor the children for long-term protection for two years.
Pfizer and BioNotech previously requested to US Food and Drug Administration as well. They wanted their emergency use permit be extended to 12–15-year-olds. The EMA had approved the COVID-19 vaccine created by Pfizer and BioNotech last December. It was the first vaccine to get the license for vaccinating people 16 and older and in the 27-country European Union.